» Articles » PMID: 12759422

IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-gamma Production in Human NK and T Cells

Overview
Journal J Immunol
Date 2003 May 22
PMID 12759422
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

NK and T cell-derived IFN-gamma is a key cytokine that stimulates innate immune responses and directs adaptive T cell response toward Th1 type. IL-15, IL-18, and IL-21 have significant roles as activators of NK and T cell functions. We have previously shown that IL-15 and IL-21 induce the expression of IFN-gamma, T-bet, IL-12R beta 2, and IL-18R genes both in NK and T cells. Now we have studied the effect of IL-15, IL-18, and IL-21 on IFN-gamma gene expression in more detail in human NK and T cells. IL-15 clearly activated IFN-gamma mRNA expression and protein production in both cell types. IL-18 and IL-21 enhanced IL-15-induced IFN-gamma gene expression. IL-18 or IL-21 alone induced a modest expression of the IFN-gamma gene but a combination of IL-21 and IL-18 efficiently up-regulated IFN-gamma production. We also show that IL-15 activated the binding of STAT1, STAT3, STAT4, and STAT5 to the regulatory sites of the IFN-gamma gene. Similarly, IL-21 induced the binding of STAT1, STAT3, and STAT4 to these elements. IL-15- and IL-21-induced STAT1 and STAT4 activation was verified by immunoprecipitation with anti-phosphotyrosine Abs followed by Western blotting with anti-STAT1 and anti-STAT4 Abs. IL-18 was not able to induce the binding of STATs to IFN-gamma gene regulatory sites. IL-18, however, activated the binding of NF-kappa B to the IFN-gamma promoter NF-kappa B site. Our results suggest that both IL-15 and IL-21 have an important role in activating the NK cell-associated innate immune response.

Citing Articles

Fucoidan alginate and sulfated alginate microbeads induce distinct coagulation, inflammatory and fibrotic responses.

Vasuthas K, Kjesbu J, Brambilla A, Levitan M, Coron A, Fonseca D Mater Today Bio. 2025; 31:101474.

PMID: 39896282 PMC: 11783016. DOI: 10.1016/j.mtbio.2025.101474.


Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma.

Chu Y, Tian M, Saini U, Ayala-Cuesta J, Klose K, Mendelowitz A Mol Ther Oncol. 2025; 33(1):200927.

PMID: 39895691 PMC: 11783442. DOI: 10.1016/j.omton.2024.200927.


Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.

Chen S, Zhu H, Jounaidi Y Signal Transduct Target Ther. 2024; 9(1):302.

PMID: 39511139 PMC: 11544004. DOI: 10.1038/s41392-024-02005-w.


Interleukin signaling in the regulation of natural killer cells biology in breast cancer.

Xu J, Gao H, Azhar M, Xu H, Chen S, Li M Front Immunol. 2024; 15:1449441.

PMID: 39380989 PMC: 11459090. DOI: 10.3389/fimmu.2024.1449441.


BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors.

Felgueres M, Esteso G, Garcia-Jimenez A, Dopazo A, Aguilo N, Mestre-Duran C Sci Rep. 2024; 14(1):13133.

PMID: 38849432 PMC: 11161620. DOI: 10.1038/s41598-024-62968-2.